W.l.gore & Associates
Clinical trials sponsored by W.l.gore & Associates, explained in plain language.
-
10-Year study tracks stent graft safety in 1,500 aortic patients
Disease control Recruiting nowThis study follows 1,500 people who received a GORE® TAG® stent graft to treat aortic conditions like aneurysms or dissections. Researchers will monitor device performance and patient outcomes for up to 10 years. The goal is to confirm that this minimally invasive procedure remai…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new graft keep dialysis access working longer?
Disease control Recruiting nowThis study follows people with end-stage kidney disease who need a vascular graft for hemodialysis. The GORE ACUSEAL graft is placed to create a reliable access point for dialysis. Researchers will track how often the graft becomes infected and how long it stays functional, aimin…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New stent graft for aortic arch disease tracked for 10 years
Disease control Recruiting nowThis study follows 125 people who received a special stent graft (GORE TAG TBE) to treat a tear or bulge in the main artery near the heart (aortic arch). The goal is to see how well the device works and how safe it is over 5 to 10 years. Participants are treated as part of their …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New stent graft could save lives from deadly aortic tear
Disease control Recruiting nowThis study tests a new device called the GORE ascending stent graft to treat a serious tear in the main artery from the heart (Type A aortic dissection). About 112 people with a recent tear will receive the stent graft through a small tube in a blood vessel, avoiding open-heart s…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Heart hole closer may cut stroke risk in mystery cases
Disease control Recruiting nowThis study tests a device called GORE® CARDIOFORM Septal Occluder to close a small hole in the heart (PFO) in people who have had a stroke with no clear cause. About 636 participants will get the device plus blood-thinning medicine. The goal is to see if this reduces the chance o…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New absorbable mesh tested for hernia repair
Disease control Recruiting nowThis study is tracking 245 hernia patients who receive the GORE ENFORM biomaterial mesh during surgery. The mesh is absorbable and used to reinforce the repair. Researchers will monitor hernia recurrence, infections, and other complications for up to two years. The goal is to see…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New stent study aims to keep blood flowing in blocked aortic arteries
Disease control Recruiting nowThis study looks at how safe and effective a special stent (VBX) is for treating blocked arteries near the aorta in the lower belly. About 158 people who already had this stent placed at least a year ago will be followed. The goal is to see if the artery stays open and if there a…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New stent graft registry aims to track safety in real patients
Disease control Recruiting nowThis registry is following 240 people who receive the GORE VIABAHN VBX stent graft to treat blocked or damaged arteries in the abdomen, pelvis, or limbs. Researchers are tracking how well the device works and any serious side effects over time. The goal is to see if the stent gra…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New stent aims to keep leg arteries open longer
Disease control Recruiting nowThis study tests whether a fabric-covered stent (GORE VBX) works better than standard bare metal stents for people with severe blockages in the iliac arteries, which supply blood to the legs. About 244 participants with leg pain or tissue loss will be randomly assigned to receive…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New Stent-Graft device under scrutiny for treating dangerous aortic aneurysms
Disease control Recruiting nowThis study follows 100 people with thoracoabdominal or pararenal aortic aneurysms who receive the GORE EXCLUDER TAMBE device, a stent-graft system placed through blood vessels. Researchers will track how often the device is successfully implanted and works without leaks or seriou…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New stent graft under scrutiny for aortic repair in japan
Disease control Recruiting nowThis study is checking how well a device called the GORE® TAG® Thoracic Branch Endoprosthesis works for people with a thoracic aortic aneurysm, dissection, or injury. About 200 patients in Japan who receive this stent graft will be followed to see if it is safe and effective. The…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New graft aims to make dialysis safer for kidney patients
Disease control Recruiting nowThis study tests a new device called the InnAVasc graft, which is surgically placed in the arm to provide a reliable access point for hemodialysis in people with end-stage kidney disease. About 133 participants will receive the graft and be followed for two years to see how well …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New device aims to improve breast reconstruction safety
Disease control Recruiting nowThis study tests a new medical device designed to reinforce breast reconstruction surgery after mastectomy. About 180 women having their first breast reconstruction will be enrolled, with some receiving the device and others having standard surgery without it. The goal is to see …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
10-Year watch on aneurysm repair devices begins
Knowledge-focused Recruiting nowThis study follows 2000 people who have or will receive a GORE EXCLUDER stent-graft to repair an abdominal aortic aneurysm (AAA). Researchers will track device safety and performance over 10 years, checking for complications like leaks, movement, or kidney problems. The goal is t…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC